| Established | 2005 |
|---|---|
| Research type | Cancer |
Field of research | Genomics, Bioinformatics, Drug Discovery, Imaging, Cancer Stem Cells, Immuno- and Bio-therapies, Clinical Trials, Health Services Research, |
| President | Dr. Laszlo Radvanyi |
| Staff | 300+ |
| Address | MaRS Centre, 661 University Avenue, Suite 510 |
| Location | Toronto, Ontario, Canada |
| Website | www |
The Ontario Institute for Cancer Research (OICR) is a not-for-profit organization based in Toronto, Ontario, Canada that focuses on research into the prevention, early detection, diagnosis and treatment of cancer.[1] OICR intends to make Ontario more effective in knowledge transfer and commercialization while maximizing the health and economic benefits of research findings for the people of Ontario.[2] OICR was launched in 2005 by the Government of Ontario, which provides funding through the Ministry of Colleges and Universities. The Institute employs more than 300 people at its research hub at the MaRS Centre in downtown Toronto and funds more than 1,900 scientific staff at hospital-based research institutes and universities around the province. In 2018 it was the highest funder of cancer research in Canada.[3]